Our findings on the ischemic animals are consistent with previous reports that show CX3CR1 deficiency intensifies microglial activation, increases IL-1β expression, and worsens the behavioral deficits in the transgenic mouse model of Alzheimer’s disease [14]. This evidence concerns the gene CX3CR1 and early-onset autosomal dominant Alzheimer disease.